Trial Profile
Evaluation of the Real-life Efficacy and Safety of a Fixed-dose Telmisartan/Hydrochlorothiazide, Including Its Effect on Plasma Potassium and on Glucose and Lipid Metabolism Parameters in Patients With Essential Arterial Hypertension.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Jul 2011
Price :
$35
*
At a glance
- Drugs Telmisartan/hydrochlorothiazide (Primary)
- Indications Essential hypertension
- Focus Therapeutic Use
- Acronyms POTASSIUM
- Sponsors Bayer
- 14 Jul 2011 New trial record